Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States—National Health and Nutrition Examination Survey, 2003–2006: Opportunity to Measure HPV Vaccine Impact?

Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006

(2011) Susan Hariri et al.   JOURNAL OF INFECTIOUS DISEASES

Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix

(2010) K. Sundstrom et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Assessing incidence and economic burden of genital warts with data from a US commercially insured population

(2009) Tracey Hoy et al.   CURRENT MEDICAL RESEARCH AND OPINION

Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women

(2009) Tasneem Shikary et al.   JOURNAL OF CLINICAL VIROLOGY

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

(2009) Suzanne M. Garland et al.   JOURNAL OF INFECTIOUS DISEASES

Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women

(2008) Eliav Barr et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY